卫光生物
(002880)
| 流通市值：63.60亿 | | | 总市值：63.82亿 |
| 流通股本：2.26亿 | | | 总股本：2.27亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 225,002,020.97 | 1,203,192,257.65 | 854,101,695.51 | 522,902,745.97 |
| 营业收入 | 225,002,020.97 | 1,203,192,257.65 | 854,101,695.51 | 522,902,745.97 |
| 二、营业总成本 | 175,409,771.72 | 900,123,198.06 | 639,313,587.41 | 392,463,709.82 |
| 营业成本 | 132,492,185.24 | 699,324,831.92 | 497,506,182.69 | 304,291,620.64 |
| 税金及附加 | 2,027,661.09 | 9,596,009.73 | 6,785,627.73 | 4,253,939.19 |
| 销售费用 | 5,122,464.1 | 29,107,358.68 | 19,886,380.85 | 12,668,145.68 |
| 管理费用 | 19,680,123.81 | 92,705,179.26 | 62,824,755.16 | 41,303,566.55 |
| 研发费用 | 11,551,806.32 | 49,052,812.69 | 38,106,155.61 | 20,867,745.9 |
| 财务费用 | 4,535,531.16 | 20,337,005.78 | 14,204,485.37 | 9,078,691.86 |
| 其中:利息费用 | 4,646,577.63 | 22,754,150.06 | 15,482,676.74 | 9,985,981.76 |
| 其中:利息收入 | 412,186.91 | 2,529,090.62 | 2,001,739.83 | 1,415,108.03 |
| 加:公允价值变动收益 | - | -14,050,642.96 | - | - |
| 加:投资收益 | 1,094,694.43 | 5,395,885.18 | -120,874.33 | -120,874.33 |
| 资产处置收益 | - | 45,819.96 | 45,819.96 | 45,819.96 |
| 信用减值损失(新) | 343,987.15 | -5,344,625.37 | -3,337,320.33 | -1,595,790.52 |
| 其他收益 | 2,284,038.25 | 7,508,043.11 | 5,900,526.52 | 3,028,462.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 53,314,969.08 | 296,623,539.51 | 217,276,259.92 | 131,796,653.83 |
| 加:营业外收入 | 9,569.25 | 1,099,345.52 | 156,818.7 | 150,940.51 |
| 减:营业外支出 | 294,303.45 | 987,746.12 | 779,388.93 | 611,858.86 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 53,030,234.88 | 296,735,138.91 | 216,653,689.69 | 131,335,735.48 |
| 减:所得税费用 | 9,306,702.26 | 42,778,142.39 | 34,127,310.27 | 21,608,387.65 |
| 六、净利润 | 43,723,532.62 | 253,956,996.52 | 182,526,379.42 | 109,727,347.83 |
| 持续经营净利润 | 43,723,532.62 | 253,956,996.52 | 182,526,379.42 | 109,727,347.83 |
| 归属于母公司股东的净利润 | 43,768,169.85 | 253,516,220.45 | 182,700,428.15 | 109,861,719.65 |
| 少数股东损益 | -44,637.23 | 440,776.07 | -174,048.73 | -134,371.82 |
| (一)基本每股收益 | 0.19 | 1.12 | 0.81 | 0.48 |
| (二)稀释每股收益 | 0.19 | 1.12 | 0.81 | 0.48 |
| 九、综合收益总额 | 43,723,532.62 | 253,956,996.52 | 182,526,379.42 | 109,727,347.83 |
| 归属于母公司股东的综合收益总额 | 43,768,169.85 | 253,516,220.45 | 182,700,428.15 | 109,861,719.65 |
| 归属于少数股东的综合收益总额 | -44,637.23 | 440,776.07 | -174,048.73 | -134,371.82 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-26 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |